Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma

NCT06364384 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Rectal Squamous Cell Carcinoma

Interventions

COMBINATION_PRODUCT: PD-1 and CRT

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University